Telomerase activity in acute myelogenous leukaemia: clinical and biological implications
暂无分享,去创建一个
B. Kim | Young Y. Lee | W. Park | J. Seol | E. S. Kim | Chul Won Jung
[1] H. Koeffler,et al. Effect of a vitamin D3 analog, EB1089, on hematopoietic stem cells from normal and myeloid leukemic blasts. , 1996, Leukemia.
[2] M. Tsuchiya,et al. Down-regulation of telomerase activity is an early event in the differentiation of HL60 cells. , 1996, Biochemical and biophysical research communications.
[3] K. Riabowol,et al. Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines. , 1996, Cancer research.
[4] J. Shay,et al. Telomeres and telomerase in human leukemias. , 1996, Leukemia.
[5] M. Mandal,et al. Cell cycle-dependent modulation of telomerase activity in tumor cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[6] B. Levine,et al. Regulated expression of telomerase activity in human T lymphocyte development and activation , 1996, The Journal of experimental medicine.
[7] J. Shay,et al. Regulation of telomerase activity in immortal cell lines , 1996, Molecular and cellular biology.
[8] E. Estey,et al. Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agents. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[9] E. Dmitrovsky,et al. Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines. , 1996, Cancer research.
[10] C. Harley,et al. Differential Expression of Telomerase Activity in Hematopoietic Progenitors from Adult Human Bone Marrow , 1996, Stem cells.
[11] M. Fackler,et al. CD34: structure, biology, and clinical utility. , 1996, Blood.
[12] A. Sartorelli,et al. Differentiation of immortal cells inhibits telomerase activity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[13] J. Shay,et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. , 1995, Journal of immunology.
[14] D. Broccoli,et al. Telomerase activity in normal and malignant hematopoietic cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[15] M. S. Rhyu. Telomeres, telomerase, and immortality. , 1995, Journal of the National Cancer Institute.
[16] B. Leber,et al. Telomerase activity in normal leukocytes and in hematologic malignancies. , 1995, Blood.
[17] K. Kinzler,et al. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. , 1995, Genes & development.
[18] W. Mercer,et al. p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. , 1995, Cancer research.
[19] C B Harley,et al. Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.
[20] Z. Su,et al. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. , 1994, Oncogene.
[21] C. Guillouf,et al. Induction of p21 (WAF-1/CIP1) during differentiation. , 1994, Oncogene.
[22] G. Roos,et al. Telomerase activity in vivo in human malignant hematopoietic cells. , 1994, Oncogene.
[23] C. Greider,et al. Telomerase activity in germline and embryonic cells of Xenopus. , 1994, The EMBO journal.
[24] S. de Vos,et al. 1,25(OH)2-16ene-vitamin D3 is a potent antileukemic agent with low potential to cause hypercalcemia. , 1994, Leukemia research.
[25] C. Harley,et al. Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes , 1994, Journal of virology.
[26] C. Harley,et al. Telomerase activity in human ovarian carcinoma. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[27] T. de Lange. Activation of telomerase in a human tumor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[28] C. Harley,et al. Telomerase, cell immortality, and cancer. , 1994, Cold Spring Harbor symposia on quantitative biology.
[29] K. Kinzler,et al. The multistep nature of cancer. , 1993, Trends in genetics : TIG.
[30] C B Harley,et al. Telomere length predicts replicative capacity of human fibroblasts. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[31] C B Harley,et al. Telomere end-replication problem and cell aging. , 1992, Journal of molecular biology.
[32] J. Shay,et al. Telomere positional effects and the regulation of cellular senescence. , 1992, Trends in genetics : TIG.
[33] J. Steitz,et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. , 1992, The EMBO journal.
[34] A. Wright,et al. New insights into genetic eye disease. , 1992, Trends in genetics : TIG.
[35] C. Harley,et al. Telomeres shorten during ageing of human fibroblasts , 1990, Nature.
[36] R. Myers,et al. Structure and variability of human chromosome ends , 1990, Molecular and cellular biology.
[37] T. Morgan,et al. Bromodeoxyuridine incorporation into DNA of human leukemia cells is not concentration dependent. , 1990, Cytometry.
[38] G. Morin. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats , 1989, Cell.
[39] V A Zakian,et al. Structure and function of telomeres. , 1989, Annual review of genetics.
[40] S. Cole,et al. Use of the MTT assay for rapid determination of chemosensitivity of human leukemic blast cells. , 1988, Leukemia research.
[41] Carol W. Greider,et al. Identification of a specific telomere terminal transferase activity in tetrahymena extracts , 1985, Cell.
[42] G Flandrin,et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. , 1985, Annals of internal medicine.
[43] H P Koeffler,et al. Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications. , 1983, Blood.
[44] J. D. Watson. Origin of Concatemeric T7DNA , 1972 .
[45] J. Yudkin. Sugar and Disease , 1972, Nature.
[46] J. Watson. Origin of concatemeric T7 DNA. , 1972, Nature: New biology.